Prescient Therapeutics LimitedASX: PTX

FDA Grants Orphan Drug Designation for PTX-200 in AML

May 1, 2017 at 3:11 AM UTC · Issued by Prescient Therapeutics Limited

Prescient Therapeutics Ltd has released a press release.

View Attachment